来自专业的译者、企业、网页和免费的翻译库。
liposarcoma
liposarkom
最后更新: 2017-04-26
使用频率: 19
质量:
liposarcoma nos
liposarkom
最后更新: 2014-12-09
使用频率: 5
质量:
myxoid liposarcoma
myxoidliposarkom
最后更新: 2014-12-09
使用频率: 15
质量:
liposarcoma, malignant
liposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
liposarcoma; embryonal
myxoidliposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
liposarcoma (diagnosis)
liposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
liposarcoma (morphologic abnormality)
liposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
translocated in liposarcoma protein
rna-binding protein fus
最后更新: 2014-12-09
使用频率: 3
质量:
liposarcoma, no icd-o subtype
liposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
myxoid liposarcoma (morphologic abnormality)
myxoidliposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
liposarcoma, myxoid [disease/finding]
myxoidliposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
[m]liposarcoma nos (morphologic abnormality)
liposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
study 309 - overall survival in the liposarcoma subgroup
studie 309 – total överlevnad i liposarkomsubgruppen
最后更新: 2017-04-26
使用频率: 1
质量:
liposarcoma, no icd-o subtype (morphologic abnormality)
liposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
liposarcoma, no international classification of diseases for oncology subtype
liposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
efficacy data are based mainly on liposarcoma and leiomyosarcoma patients.
effektdata är huvudsakligen baserade på patienter med liposarkom och leiomyosarkom.
最后更新: 2012-04-11
使用频率: 2
质量:
liposarcoma, no international classification of diseases for oncology subtype (morphologic abnormality)
liposarkom
最后更新: 2014-12-09
使用频率: 1
质量:
the committee noted that evidence of yondelis’ s effects is mainly based on the treatment of liposarcoma and leiomyosarcoma.
kommittén noterade att bevisen på yondelis effekter huvudsakligen baseras på behandling av liposarkom och leiomyosarkom.
最后更新: 2012-04-11
使用频率: 2
质量:
halaven was also studied in 143 patients with liposarcoma who had previously undergone at least two other treatments, which included an anthracycline.
halaven undersöktes också på 143 patienter med liposarkom som tidigare hade genomgått minst två andra behandlingar där det ingick en antracyklin.
最后更新: 2017-04-26
使用频率: 1
质量:
additionally, halaven prolonged the length of time that liposarcoma patients lived, and this was considered important as these patients have limited treatment options.
halaven ökade dessutom den tid patienter med liposarkom levde och detta ansågs viktigt eftersom dessa patienter har begränsade behandlingsalternativ.
最后更新: 2017-04-26
使用频率: 1
质量: